Continuous glucose monitoring devices are medical devices used for monitoring glucose level in people with diabetes. These devices help in measuring glucose levels in fluid under the skin (interstitial fluid) or in blood through a tiny sensor inserted just beneath the skin. The continuous glucose monitoring systems provide real-time updates on glucose levels which enable faster insulin therapy decisions. Reading of glucose levels through these devices helps patients adapt their lifestyle and diet accordingly to keep diabetes in control.
Key Takeaways
Key players operating in the China continuous glucose monitoring market are Abbott Laboratories, Dexcom Inc., Senseonics Holdings Inc., Medtronic plc.
The China Continuous Glucose Monitoring Devices Market Demand offers immense growth opportunities owing to rising government initiatives promoting CGM adoption along with favorable reimbursement policies. Increasing awareness among patients and physicians regarding benefits of CGMs is further driving the demand.
Major players are focused on expanding their presence in China by strengthening their distribution networks across the country. Strategic collaborations with local players are helping global companies penetrate untapped regional markets and rural areas.
Market drivers
The continuous glucose monitoring devices market in China is primarily driven by the growing prevalence of diabetes. As per the International Diabetes Federation, China has the largest diabetes population in the world with an estimated 116 million cases in 2021. Diabetes management has become a key focus area for Chinese healthcare system to curb rising medical costs associated with the disease. Increasing preference for non-invasive monitoring solutions will further boost adoption of CGMs over the forecast period.
Get More Insights on- China Continuous Glucose Monitoring Devices Market
For Deeper Insights, Find the Report in the Language that You want:
